cefoperazone has been researched along with Healthcare-Associated Pneumonia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Chen, CM; Chen, WC; Fang, WF; Fu, PK; Huang, CT; Ku, SC; Kuo, LK; Lai, CC; Tu, CY; Wang, YT | 1 |
| Wu, F; Zhou, X | 1 |
| Chen, YH; Chen, YS; Chuang, YC; Huang, CT; Ko, WC; Lee, WS; Lin, HH; Lin, JC; Liu, JW; Liu, YC; Lu, MC; Tang, HJ; Wang, FD | 2 |
1 trial(s) available for cefoperazone and Healthcare-Associated Pneumonia
| Article | Year |
|---|---|
Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cefoperazone; Drug Therapy, Combination; Female; Haemophilus Infections; Healthcare-Associated Pneumonia; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas Infections; Sulbactam; Treatment Outcome | 2019 |
3 other study(ies) available for cefoperazone and Healthcare-Associated Pneumonia
| Article | Year |
|---|---|
Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cohort Studies; Community-Acquired Infections; Female; Frail Elderly; Healthcare-Associated Pneumonia; Humans; Male; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Treatment Outcome | 2022 |
Be Careful with Adverse Events Caused by Cefoperazone-Sulbactam.
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Healthcare-Associated Pneumonia; Humans; Sulbactam | 2020 |
Reply to Zhou and Wu, "Be Careful with Adverse Events Caused by Cefoperazone-Sulbactam".
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Healthcare-Associated Pneumonia; Humans; Sulbactam | 2020 |